glp-1 drug market size Receptor Agonist & Analysis, 2026-2033 GLP-1 Drugs Market Size to
Description
Not everyone, however, has a great response to GLP-1 drugs and they can cause unpleasant side effects, like nausea, constipation and diarrhoea
GLP-1 agonists have also shown strong efficacy in clinical trials, with patients achieving an average weight loss of 15-25%, further promoting rapid adoption
(2024, February 29)
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
It is a clinical one
